COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,169 Articles (22,703 medRxiv, 8,466 bioRxiv)

Most recent first Previous |  Page 937: Articles 9361-9370  | Next

Emulation of a target trial from observational data to compare effectiveness of Casirivimab/Imdevimab and Bamlanivimab/Etesevimab for early treatment of non-hospitalized patients with COVID-19
Mazzotta, V., Cozzi-Lepri, A., Colavita, F., Lanini, S., Rosati, S., Lalle, E., Mastrorosa, I., Cimaglia, C., Vergori, A., Bevilacqua, N., Lapa, D., Mariano, A., Bettini, A., Agrati, C., Piselli, P., Girardi, E., Castilletti, C., Garbuglia, A. R., Vaia, F., Nicastri, E., Antinori, A.
10.1101/2022.02.04.22270143 — Posted: 2022-02-06
Comparative study of immunogenicity and safety of Gam-COVID-Vac and Sinopharm BBIBP-CorV vaccines in Belarus
Stoma, I., Korsak, K., Voropaev, E., Osipkina, O., Kovalev, A.
10.1101/2022.02.05.22270499 — Posted: 2022-02-06
The usefulness of D-dimer as a predictive marker for mortality in patients with COVID-19 hospitalized during the first wave in Italy.
Hassan, S., Ferrari, B., Rossio, R., la Mura, V., Artoni, A., Gualtierotti, R., Martinelli, I., Nobili, A., Bandera, A., Gori, A., Blasi, F., Monzani, V., Costantino, G., Harari, S., Rosendaal, F. R., Peyvandi, F., the COVID-19 Network working group
10.1101/2022.02.04.22270433 — Posted: 2022-02-06
USA Winter 2021 CoVID-19 Resurgence Post-Christmas Update
Eng, G.
10.1101/2022.02.04.22270491 — Posted: 2022-02-06
Interactions among 17 respiratory pathogens: a cross-sectional study using clinical and community surveillance data
Burstein, R., Althouse, B. M., Adler, A., Akullian, A., Brandstetter, E., Cho, S., Chung, E., Emmanuels, A., Fay, K., Gamboa, L., Han, P., Huden, K., Ilcisin, M., Izzo, M., Jackson, M. L., Kim, A. E., Kimball, L., Lacombe, K., Lee, J., Logue, J. K., Rogers, J., Sibley, T. R., Van Raay, K., Wenger, E., Wolf, C. R., Boeckh, M., Chu, H., Duchin, J., Reider, M., Shendure, J., Starita, L. M., Viboud, C., Bedfor, T., Englund, J. A., Famulare, M., Seattle Flu Study and SCAN Investigators
10.1101/2022.02.04.22270474 — Posted: 2022-02-06
Attitudes Towards Coronavirus (COVID-19) Vaccine and Sources of Information Across Diverse Ethnic Groups in the UK: a Qualitative Study
Sides, E., Jones, L. F., Kamal, A., Thomas, A., Syeda, R., Kaissi, A., Lecky, D., Patel, M., Nellums, L., Greenway, J., Campos-Matos, I., Shukla, R., Brown, C., Pareek, M., Sollars, L., Pawson, E., McNulty, C.
10.1101/2022.02.04.22270456 — Posted: 2022-02-06
Post-peak dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022
Elliott, P., Eales, O., Bodinier, B., Tang, D., Wang, H., Jonnerby, J., Haw, D., Elliott, J., Whitaker, M., Walters, C. E., Atchinson, C., Diggle, P. J., Page, A. J., Trotter, A., Ashby, D., Barclay, W., Taylor, G., Ward, H., Darzi, A., Cooke, G., Chadeau-Hyam, M., Donnelly, C. A.
10.1101/2022.02.03.22270365 — Posted: 2022-02-06
Effective high-throughput RT-qPCR screening for SARS-CoV-2 infections in children
Dewald, F., Suarez, I., Johnen, R., Grossbach, J., Tovar, R., Steger, G., Joachim, A., Rubio, G., Fries, M., Behr, F., Kley, J., Lingnau, A., Kretschmer, A., Gude, C., Flores, G., del Valle, D., Hernandez, A., Cerino, J., Hernandez, A., Quinones, J., Schega, K., Linne, V., Junker, L., Wunsch, M., Heger, E., Knops, E., Di Cristanziano, V., Meyer, M., Huenseler, C., Weber, L. T., Lueers, J., Quade, G., Wisplinghoff, H., Tiemann, C., Zotz, R., Jomaa, H., Pranada, A., Herzum, I., Cullen, P., Schmitz, F., Philipsen, P., Kirchner, G., Knabbe, C., Hellmich, M., Buess, M., Wolf, A., Kossow, A., Niessen, J., Jeworutzki, S., Schraepler, J., Laessig, M., Doetsch, J., Faetkenheuer, G., Kaiser, R., Beyer, A., Rybniker, J., Klein, F.
10.1101/2022.02.04.22270304 — Posted: 2022-02-06
Effects of socio-economic factors on elementary school student COVID-19 infections in Ontario, Canada
Srivastava, P., Lau, N. T. T., Ansari, D., Thampi, N.
10.1101/2022.02.04.22270413 — Posted: 2022-02-06
Minimizing school disruption under high incidence conditions due to the Omicron variant in early 2022
Colosi, E., Bassignana, G., Barrat, A., Lina, B., Vanhems, P., Bielicki, J., Colizza, V.
10.1101/2022.02.04.22270473 — Posted: 2022-02-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).